CPRT vs PCSA · P/E 19, rev $3.51B vs $5.9M cap
Copart Inc (CPRT) versus Processa Pharmaceuticals Inc (PCSA) — a side-by-side from cached financials, not a winner call.
Copart Inc (CPRT) is a specialty business services company listed on US.
Processa Pharmaceuticals Inc (PCSA) is a biotechnology company listed on NASDAQ.
Latest reported CPRT revenue for 2026-04-30 was $3.51B. Net income was $1.16B. Revenue was up 54.3% from 2026-01-31 to 2026-04-30. CPRT currently screens at market cap $28.66B and trailing P/E 19.2.
PCSA does not have a complete income-statement cache yet.
CPRT currently screens at market cap $28.66B and trailing P/E 19.2. PCSA currently screens at market cap $5.9M.
Not investment advice. Open the CPRT and PCSA stock pages for the full models.
Not investment advice.